Australia markets closed

Pharming Group N.V. (PHAR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.74+0.36 (+3.47%)
At close: 10:57AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
202,397
198,871
228,395
189,334
154,576
Cost of revenue
20,561
21,142
25,338
23,921
25,372
Gross profit
181,836
177,729
203,056
165,412
129,204
Operating expenses
Research development
75,459
70,369
41,464
31,777
33,038
Selling general and administrative
90,820
81,696
69,968
65,896
53,489
Total operating expenses
159,334
158,721
120,971
97,186
85,745
Operating income or loss
22,502
19,008
82,086
68,226
43,459
Interest expense
5,674
6,091
6,398
13,349
16,370
Total other income/expenses net
-4,754
-4,639
-28,912
-3,721
-26,129
Income before tax
26,844
23,078
47,465
52,289
980.3249
Income tax expense
5,997
7,082
6,834
11,744
-27,609
Income from continuing operations
20,847
15,996
40,631
40,545
28,590
Net income
20,847
15,996
40,631
40,545
28,590
Net income available to common shareholders
20,847
15,996
40,631
40,545
28,590
Basic EPS
-
0.24
0.63
0.65
0.47
Diluted EPS
-
0.22
0.59
0.60
0.43
Basic average shares
-
64,229
63,627
62,632
60,662
Diluted average shares
-
70,989
68,274
67,352
65,353
EBITDA
-
48,779
62,812
71,437
24,854